Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Wave Life Sciences (WVE) Non-Current Receivables (2018 - 2020)

Wave Life Sciences' Non-Current Receivables history spans 3 years, with the latest figure at $30.0 million for Q1 2020.

  • For Q1 2020, Non-Current Receivables fell 40.0% year-over-year to $30.0 million; the TTM value through Mar 2020 reached $30.0 million, down 40.0%, while the annual FY2019 figure was $30.0 million, 40.0% down from the prior year.
  • Non-Current Receivables reached $30.0 million in Q1 2020 per WVE's latest filing, roughly flat from $30.0 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $50.0 million in Q2 2018 to a low of $30.0 million in Q2 2019.
  • Average Non-Current Receivables over 3 years is $40.0 million, with a median of $40.0 million recorded in 2018.
  • The largest YoY upside for Non-Current Receivables was 40.0% in 2019 against a maximum downside of 40.0% in 2019.
  • A 3-year view of Non-Current Receivables shows it stood at $50.0 million in 2018, then tumbled by 40.0% to $30.0 million in 2019, then changed by 0.0% to $30.0 million in 2020.
  • Per Business Quant, the three most recent readings for WVE's Non-Current Receivables are $30.0 million (Q1 2020), $30.0 million (Q4 2019), and $30.0 million (Q3 2019).